Key points are not available for this paper at this time.
Incorporating fluorine into azoles is not only a common practice but also an essential tactic in medicinal chemistry, due to their ability to fine-tune a molecule's physicochemical, pharmacokinetic, and pharmacodynamic profiles. The strategic introduction of fluorine into nitrogen-containing five-membered heterocycles can significantly enhance metabolic stability, membrane permeability, and binding affinity-key factors in modern drug development. This review provides an up-to-date overview of key synthetic strategies for monofluorination, difluoromethylation, and trifluoromethylation across 11 prominent azoles: 1,2,3-triazoles, 1,2,4-triazoles, tetrazoles, pyrazoles, imidazoles, pyrroles, isoxazoles, oxazoles, thiazoles, thiadiazoles, and isothiazoles. This review aims to identify current limitations in the field and delineate existing research gaps that present further opportunities for innovation in these domains, which are essential for propelling pharmaceutical and biomedical research. By integrating new synthetic advancements and diverse strategies to access them, this review aims to serve as both a practical guide and a source of inspiration for chemists exploring the next generation of fluorinated azole pharmaceuticals.
El‐Gaber et al. (Mon,) studied this question.